Cochlear Limited
COH
Rank in Stocks
#3046
Globally, Cochlear Limited specializes in the development and provision of... Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Share Price
$92.94
Market Cap
$6.08B
Change (1 day)
-0.28%
Change (1 year)
-49.94%
Country
AU
Trade Cochlear Limited (COH)
Category
Healthcare
EPS for Cochlear Limited (COH)
EPS as of June 2026 TTM: $1.59
According to Cochlear Limited latest financial reports and stock price the company's current EPS (TTM) is $1.59. At the end of 2024 the company had a EPS of $3.63 an increase over its 2023 EPS that were of $3.04.
EPS history for Cochlear Limited from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $1.59 | -59.41% |
| 2025 | $3.91 | 7.65% |
| 2024 | $3.63 | 19.29% |
| 2023 | $3.04 | 0.33% |
| 2022 | $3.03 | -17.90% |
| 2021 | $3.70 | -229.72% |
| 2020 | $-2.85 | -184.36% |
| 2019 | $3.38 | 6.57% |
| 2018 | $3.17 | 5.55% |
| 2017 | $3.00 | 21.79% |
| 2016 | $2.47 | 25.10% |
| 2015 | $1.97 | 26.64% |
| 2014 | $1.56 | -26.90% |
| 2013 | $2.13 | 108.34% |
| 2012 | $1.02 | -70.03% |
| 2011 | $3.41 | 45.88% |
| 2010 | $2.34 | 23.46% |
| 2009 | $1.89 | -5.11% |
| 2008 | $2.00 | 28.41% |
| 2007 | $1.55 | 42.34% |
| 2006 | $1.09 | 43.49% |
| 2005 | $0.76 | 61.08% |
| 2004 | $0.47 | -35.97% |
| 2003 | $0.74 | 70.03% |
| 2002 | $0.43 | 42.23% |
| 2001 | $0.31 | 27.35% |
| 2000 | $0.24 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.11 | 95.98% |
US
|
|
| $3.59 | 126.23% |
IE
|
|
| $9.73 | 513.15% |
US
|
|
| $2.48 | 56.28% |
US
|
|
| - | - |
DE
|
